AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2024
Nov 6, 2024
34491_dirs_2024-11-05_0b8a3d22-d24e-479f-b02b-26c7b948e2e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2024-11-02
Reporting Person: Scimeca Dario (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-02 | Common Stock | M | 1836 | — | Acquired | 8557 | Direct |
| 2024-11-04 | Common Stock | S | 588 | $8.19 | Disposed | 7969 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-02 | Restricted Stock Units | $ | M | 1836 | Disposed | Common Stock (1836) | Direct |
Footnotes
F1: Represents the vesting of Restricted Stock Units ("RSUs") on November 2, 2024.
F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F3: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
F4: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.